Adjunct Professor in Medical Biochemistry
PhD, Docent – FT, Dosentti
![]() |
Thesis: Bactericidal proteins group IIA phospholipase A2 and bactericidal/permeability-increasing protein in human lacrimal gland and tears
|
Håkansson M, Salminen K, Kuosmanen P, Eskola J, Peuravuori H, Kulmala S
Immunoassay of ß2-microglobulin at oxide-coated heavily doped p-silicon electrodes.
J Electroanal Chem 2016; 769: 11 – 15Peuravuori H, Kollanus S, Nevalainen TJ
Expression of group XIIA phospholipase A2 in human digestive organs.
APMIS 2014; 122: 1171-1177Uusitalo-Seppälä R, Peuravuori H, Koskinen P, Vahlberg T, Rintala EM
Role of plasma bactericidal/permeability-increasing protein, group IIA phospholipase A2, C-reactive protein and white blood cell count in early detection of severe sepsis in the emergency department.
Scand J Infect Dis 2012; 44: 697-704Uusitalo-Seppälä R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM
Early detection of severe sepsis in the emergency room: Diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6.
Scand J Infect Dis 2011; 43: 883-890Kahl S, Mayer J, Schuette K, Peuravuori H, Pross M, Schulz HU, Nevalainen TJ, Malfertheiner P
Effect of procainhydrochloride on phospholipase A2 catalytic activity in sodium taurocholate-induced acute experimental pancreatitis in rats.
Dig Dis 2010; 28: 373-378Kari O, Peltonen S, Saari JM, Kari M, Peuravuori H, Saari KM
GIIAPLA2 content of tears in non-allergic eosinophilic conjunctivitis.
Acta Ophthalmologica 2009; 237-238Haapamäki MM, Grönroos JM, Nurmi H, Irjala K, Peuravuori H, Nevalainen TJ
Laboratory blood tests in Crohn’s disease. Value of blood tests including serum groups IIA phospholipase A2 and bactericidal/permeability-increasing protein in Crohn’s disease.
Scand J Clin Lab Invest 2006; 66: 585-594Sippola T, Aho H, Peuravuori H, Lukkarinen H, Gunn J, Kääpä P
Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration.
Pediatr Res 2006; 59: 641-645Peuravuori H, Aho VV, Aho HJ, Collan Y, Saari KM
Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects.
Graefe’s Arch Clin Exp Ophthalmol 2006; 244: 143-148Peuravuori H, Kari O, Aho VV, Saari J, Collan Y, Saari KM
Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitis.
Graefe’s Arch Clin Exp Ophthalmol 2004; 242: 986-989Nevalainen TJ, Peuravuori HJ, Quinn RJ, Llewellyn LE, Benzie JAH, Fenner PJ, Winkel KD
Phospholipase A2 in Cnidaria.
Comp Biochem Physiol B Biochem Mol Biol 2004; 139: 731-735Korhonen K, Soukka H, Halkola L, Peuravuori H, Aho H, Pulkki K, Kero P, Kääpä PO
Meconium Induces Only Localized Inflammatory Lung Injury in Piglets.
Pediatr Res 2003; 54: 192-197.Aho VV, Paavilainen V, Nevalainen TJ, Peuravuori H, Saari KM
Diurnal variation in group IIa phospholipase A2 content in tears of contact lens wearers and normal controls
Graefes Arch Clin Exp Ophthalmol 2003; 241: 85-88Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, Andersson S
Extracellular release of bactericidal/permeability-increasing protein in newborn infants
Pediatr Res 2002; 51: 670-674Rintala E, Peuravuori H, Pulkki K, Voipio-Pulkki LM, Nevalainen T
Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome
Intensive Care Med 2000; 26: 1248-1251Punzi L, Peuravuori H, Jokilammi-Siltanen A, Bertazzolo N, Nevalainen TJ
Bactericidal/permeability increasing protein and proinflammatory cytokines in synovial fluid of psoriatic arthritis
Clin Exp Rheumatol 2000; 18: 613-615Holopainen R, Aho H, Laine J, Peuravuori H, Soukka H, Kääpä P
Human meconium has high phospholipase A2 activity and induces cellular injury and apoptosis in piglet lungs.
Pediatr Res 1999; 46: 626-632Hietaranta A, Kemppainen E, Puolakkainen P, Sainio V, Haapiainen R, Peuravuori H, Kivilaakso E, Nevalainen T
Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis
Pancreas 1999; 18: 385-391Haapamäki MM, Grönroos JM, Nurmi H, Söderlund K, Peuravuori H, Alanen K, Nevalainen TJ
Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn’s disease
Clin Chem Lab Med 1998; 36: 751-755Aho HJ, Grenman R, Sipilä J, Peuravuori H, Hartikainen J, Nevalainen TJ
Group II phospholipase A2 in nasal fluid, mucosa and paranasal sinuses
Acta Otolaryngol 1997; 117: 860-863Peuravuori H, Kunelius R, Eskola J, Korpela T
Inorganic pyrophosphatase-labelled enzyme immunoassay for beta 2-microglobulin
J Immunol Methods 1997; 204: 161-167Laine VJ, Nyman KM, Peuravuori HJ, Henriksen K, Parvinen M, Nevalainen TJ
Lipopolysaccharide induced apoptosis of rat pancreatic acinar cells.
Gut 1996; 38: 747-752Häggblom J-O, Jokilammi-Siltanen AB, Peuravuori H, Nevalainen TJ.
Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein.
Mediat Inflamm 1996; 5: 47 – 50Hietaranta AJ, Peuravuori HJ, Nevalainen TJ
Phospholipase A2 in sodium taurocholate-induced experimental hemorrhagic pancreatitis in the rat
J Surg Res 1995; 59: 271-278Nevalainen TJ, Aho HJ, Peuravuori H
Secretion of group 2 phospholipase A2 by lacrimal glands
Invest Ophthalmol Vis Sci 1994; 35: 417-421Peuravuori HJ, Funatomi H, Nevalainen TJ
Group I and group II phospholipases A2 in serum in uraemia
Eur J Clin Chem Clin Biochem 1993; 31: 491-494Peuravuori H, Korpela T
Pyrophosphatase-based enzyme-linked immunosorbent assay of total IgE in serum
Clin Chem 1993; 39: 846-851
Congress abstracts
Kari O, Aho V, Peuravuori H, Peltonen S, Saari J, Määttä M, Collan Y, Saari M
Group IIA phospholipase A2 content of tears in patients with atopic blepharoconjunctivitis and ocular rosacea.
Acta Ophthalmologica (Scandinavica), 2006; 84: 76Collan Y, Talve L, Peuravuori H
Strategy of a pathology department in respect to virtual microscopy. Abstract Book, 7th European Congress on Telepathology & 1st International Congress on Virtual Microscopy, 2004; 22Kahl S, Leodolter A, Glasbrenner B, Schulz H-U, Pross M, Mantke R, Peuravuori H, Nevalainen T, Malfertheiner P
Effect of procain-HC1 on phospholipase A2 in experimental acute pancreatitis. Gastroenterology 118 (Part 1 Suppl. 2), 2000; A426-A427Holopainen R, Laine J, Peuravuori H, Halkola L, Aho H, Kääpä P.
Meconium aspiration has high phospholipase A2 activity and induces inflammatory injury and apoptosis in piglet lungs. Pediatric Academic Societies 1999 Annual meeting. San Francisco, USA. 1999Mayer J, Peuravuori H, Rau B, Hermon-Taylor J, Nevalainen TJ, Beger HG
Phospholipase A2 activation peptide found in human neutrophil granulozytes does not originate from immunoreactive pancreatic phospholipase A2.
Gastroenterology 112 (Suppl. S), 1997; A1458Nevalainen T, Hietaranta A, Kemppainen E, Peuravuori H, Puolakkainen P, Sainio V, Haapiainen R, Kivilaakso E
Phospholipases A2 and bactericidal/permeability increasing protein in acute pancreatitis.
Digestion 58 (Suppl. 2), 1997; 42Hietaranta A, Kemppainen E, Peuravuori H, Puolakkainen P, Sainio V, Haapiainen R, Kivilaakso E, Nevalainen T
Bactericidal/permeability-increasing protein (BPI), group II phospholipase A2 (PLA2) and pancreatic PLA2 in acute pancreatitis.
Gastroenterology 112 (Suppl), 1997; A448Saari KM, Saaren-Seppälä H, Aho HJ, Peuravuori H, Nevalainen TJ
Synthesis and secretion of lysozyme and group 2 phospholipase A2 in lacrimal glands. Proceedings of the Tenth Congress of European Society of Ophthalmology, Milano June 25-29, 1995Laine VJO, Nyman K, Peuravuori HJ, Nevalainen TJ
Lipopolysaccharide-induced apoptosis of rat pancreatic acinar cells, XXVIth Meeting Bologna, Italy, September 7 – 10.
Digestion, 1994; 55: 310Hietaranta AJ, Peuravuori HJ, Nevalainen TJ
Phospholipase A2 in experimental hemorrhagic acute pancreatitis. Abstract Book, XXVIII Congress of The European Society for Surgical Research (ESSR). Turku, Finland, May 23-26, 1993; P-183Peuravuori H, Saarento H, Korpela T
Generation of murine monoclonal anti-human IgE and the use in immunoassay for total serum IgE. Abstracts of 8th European Congress of Clinical Chemistry and 21st National Congress of the Italian Society of Clinical Biochemistry, Milano Italy, 1989; 296
